HTT and Huntington disease: ZFP also displayed dose-dependent effectiveness, reduced protein aggregation, and alleviated behavioral symptoms in R6/2 mice, demonstrating the potential of using synthetic transcription factor inhibitors to decrease HTT expression in the brain in the context of HD (Garriga-Canut et al., 2012).